mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.03 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.03 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |